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SUMMARY 30 
Burkholderia cenocepacia employs a Type VI secretion system (T6SS) to survive in 31 
macrophages by disarming Rho-type GTPases, causing actin cytoskeletal defects. Here, 32 
we identified TecA (T6SS effector affecting cytoskeletal architecture), a non-VgrG T6SS 33 
effector responsible for disrupting actin cytoskeleton. TecA and other bacterial homologs 34 
bear a cysteine protease-like catalytic triad, which inactivates Rho GTPases by catalyzing 35 
deamidation of a specific asparagine in Rho. TecA deamidation of Rho activates the 36 
canonical inflammasome and pyroptotic cell death in infected macrophages and dendritic 37 
cells, which is mediated by the familial Mediterranean fever disease protein Pyrin. The 38 
physiological function of TecA is recapitulated in mouse lung infections, in which its 39 
deamidase activity is necessary and sufficient for B. cenocepacia-triggered lung 40 
inflammation. Detection of TecA by Pyrin is protective on mice from lethal B. 41 
cenocepacia infection. Therefore, Burkholderia TecA is a novel T6SS effector that 42 
modifies a eukaryotic target through a unique asparagine deamidase activity, which 43 
elicits host cell death and inflammation due to activation of the Pyrin inflammasome. 44 
45 
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INTRODUCTION 46 
The type VI-secretion system (T6SS) is a contractile nanomachine widely distributed in 47 
Gram-negative bacteria (Basler et al., 2012; Boyer et al., 2009; Clemens et al., 2015; 48 
Kudryashev et al., 2015; Zoued et al., 2014). The T6SS structurally resembles the 49 
bacteriophage tail injection device; the tail tube is made of the Hcp protein and a 50 
puncturing device containing proteins of the VgrG family and various VgrG-associated 51 
proteins caps the Hcp tube (Zoued et al., 2014). Upon cell contact, the T6SS delivers 52 
toxic effectors into neighboring target cells. Most of the known T6SS effectors act on 53 
bacterial competitors cells and include peptidoglycan-, membrane-, and nucleic acid-54 
targeting enzymes (Durand et al., 2014; Russell et al., 2014).  55 
Among T6SS effectors that act on eukaryotic cells, the "evolved" VgrG proteins (also 56 
required for assembly of the T6SS apparatus) are the most established. The P. aeruginosa 57 
VgrG2b contains a Zn2+-dependent metalloprotease domain and interacts with tubulin 58 
components (Sana et al., 2015), while VgrG1 proteins from Vibrio cholerae and 59 
Aeromonas hydrophila contain an actin cross-linking domain (Durand et al., 2012) and an 60 
ADP-ribosylating domain (Suarez et al., 2010), respectively. Other evolved VgrGs from 61 
V. parahaemolyticus and B. pseudomallei have effects on autophagy and host cell fusion 62 
(Schwarz et al., 2014; Toesca et al., 2014; Yu et al., 2015) with unknown molecular 63 
mechanisms. In contrast, few non-VgrG T6SS effectors have been reported. The VasX 64 
protein from V. cholerae contains an N-terminal pleckstrin domain that interacts with 65 
phospholipids and can compromise the inner membrane of prokaryotic target cells 66 
(Miyata et al., 2011; Miyata et al., 2013); the PldA/B proteins from P. aeruginosa are 67 
phospholipases and their expression is associated with PI3K/Akt activation in infected 68 
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eukaryotic cells (Jiang et al., 2014); EvpP from Edwarsiella tarda is necessary for 69 
virulence of the bacteria (Zheng and Leung, 2007). However, the physiological function 70 
of these non-VgrG effectors is not well established and it remains to be conclusively 71 
demonstrated that these proteins are bona fide T6SS effectors specifically modulating 72 
eukaryotic host functions. 73 
Burkholderia cenocepacia is an environmental Gram-negative opportunistic pathogen 74 
that causes severe chronic lung infection in cystic fibrosis patients (Drevinek and 75 
Mahenthiralingam, 2010). B. cenocepacia is pathogenic in plant and non-mammalian 76 
animal infection models (Khodai-Kalaki et al., 2015; Uehlinger et al., 2009; Vergunst et 77 
al., 2010), and survives intracellularly within amoebae and macrophages (Valvano et al., 78 
2012). Unlike other cystic fibrosis pathogens, B. cenocepacia does not form biofilms in 79 
the lungs of infected patients and resides primarily within human mucosal macrophages 80 
(Schwab et al., 2014). Intramacrophage B. cenocepacia delays phagosomal maturation, 81 
alters the actin cytoskeleton, and triggers inflammation and cell death (Valvano et al., 82 
2012). B. cenocepacia infection and pathogenesis critically requires the function of a 83 
T6SS. The B. cenocepacia T6SS inactivates Rho family GTPases, which reduces the 84 
phagocytic capacity of macrophages (Flannagan et al., 2012; Rosales-Reyes et al., 2012), 85 
blocks NADPH oxidase assembly onto the B. cenocepacia-containing vacuole (Keith et 86 
al., 2009; Rosales-Reyes et al., 2012), and disrupts the macrophage's actin cytoskeleton 87 
(Aubert et al., 2008; Flannagan et al., 2012; Rosales-Reyes et al., 2012). The T6SS also 88 
leads to activation of the canonical caspase-1 inflammasome, interleukin (IL)-1/18 89 
secretion and pyroptosis in macrophages (Gavrilin et al., 2012; Xu et al., 2014). 90 
Pyroptosis is a programmed, necrotic cell death that causes exaggerated proinflammatory 91 
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responses and ultimately tissue damage. Inflammasome activation after B. cenocepacia 92 
infection in macrophages involves Pyrin (Xu et al., 2014), an intracellular innate immune 93 
sensor that detects pathogen-induced modifications of Rho GTPases (Xu et al., 2014; 94 
Yang et al., 2014). Interestingly, gain-of-function mutations in Pyrin are the cause for 95 
familial Mediterranean fever, an autoinflammatory disease in humans. 96 
Despite the genetic requirement of the T6SS in B. cenocepacia for manipulating host 97 
function, no T6SS effectors involved in the cellular changes of infected macrophages 98 
have been identified. In fact, no effector-encoding genes appear to be present in the T6SS 99 
core cluster and neither the candidate VgrG nor VgrG-associated proteins are responsible 100 
for the actin cytoskeletal rearrangements (Aubert et al., 2015). Here, we performed 101 
genetic screen in B. cenocepacia and identified TecA (T6SS effector protein affecting 102 
cytoskeletal architecture), a non-VgrG T6SS effector with a unique deamidase activity. 103 
Specific deamidation by TecA of a critical asparagine residue in RhoA and Rac1 104 
GTPases causes their inactivation and disruption of host actin cytoskeleton. TecA defines 105 
a novel family of bacterial cysteine protease-like enzymes that catalyze asparagine 106 
deamidation of Rho GTPases. TecA deamidation of RhoA drives activation of the Pyrin 107 
inflammasome in infected macrophages and dendritic cells. This innate immune response 108 
mediates lung inflammation during intranasal B. cenocepacia infection in mice, and can 109 
also protect the mice from lethal peritoneal B. cenocepacia infection. TecA is the first 110 
bacterial toxin secreted by an intracellular pathogen that targets the switch I region of 111 
Rho GTPases and inactivates their function by deamidation of an essential asparagine 112 
residue.  113 
 114 
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RESULTS 115 
Identification of a non-VgrG T6SS effector in B. cenocepacia that drives host actin 116 
cytoskeleton rearrangements 117 
B. cenocepacia infection disrupts the actin cytoskeleton in macrophages, forming “beads 118 
on a string”-like structures featuring long extensions with bleb-like structures located 119 
along the extensions and surrounding the cell periphery (Aubert et al., 2008; Flannagan et 120 
al., 2012; Rosales-Reyes et al., 2012). This phenotype reflects a collapse of the actin 121 
filaments in the lamellipodia and defective retraction during migration, and is dependent 122 
upon a functional T6SS (Aubert et al., 2008; Flannagan et al., 2012; Rosales-Reyes et al., 123 
2012). The T6SS activity in B. cenocepacia can be stimulated by deleting AtsR 124 
(Adhesion and Type Six secretion system Regulator), a hybrid sensor kinase of a two-125 
component system (Aubert et al., 2010; Aubert et al., 2008; Aubert et al., 2013; Khodai-126 
Kalaki et al., 2013). This ensures uniform high expression of the T6SS genes and 127 
provides higher reproducibility of the results, especially in strain K56-2 that does not 128 
have a high macrophage infection index. Consistently, infection of macrophages with the 129 
ΔatsR mutant of B. cenocepacia K56-2 results in increased formation of “beads on a  130 
string”-like structures (Aubert et al., 2008; Flannagan et al., 2012; Rosales-Reyes et al., 131 
2012). We recently developed a densitometry assay that quantifies the extent of this 132 
phenotype (Aubert et al., 2015). Using this assay, we performed random transposon 133 
mutagenesis screens in the ΔatsR background to search for bacterial mutants unable to 134 
induce disruption of the actin cytoskeleton in macrophages. 27 mutants were identified 135 
from the initial screen of 2,700 independent transposon mutants, and 6 of them (all 136 
having transposon insertions outside of the T6SS cluster) did not pass further 137 
 8 
confirmation by targeted deletion of the gene disrupted by the transposon. Among the 138 
remaining 21 mutants incapable of inducing “beads on a string”-like structures, 20 had a 139 
transposon inserted into genes encoding critical core components of the T6SS apparatus 140 
(Figure 1A). The last insertion mutant was in BCAM1857 (GenBank: CAR55715.1), a 141 
gene located on chromosome 2 and outside of the T3SS locus (Figure 1A). Deletion of 142 
BCAM1857 in ΔatsR resulted in a strain unable to induce formation of the “beads on a 143 
string”-like structures in macrophages (Figure 1B-C). This phenotype could be restored 144 
to parental levels by introducing in the strain a plasmid expressing the BCAM1857 145 
protein (Figure 1B-C). Therefore, BCAM1857 could be a putative non-VgrG T6SS 146 
effector responsible for cytoskeletal changes in macrophages and was renamed TecA 147 
(T6SS effector protein affecting cytoskeletal architecture). 148 
Growth curves and gentamicin protection assays indicated that B. cenocepacia 149 
ΔatsRΔtecA grows at a similar rate as the ΔatsR parent strain in LB medium as well as in 150 
immortalized murine macrophages (Figure S1A and S1B). Similar Hcp levels were 151 
detected in ΔatsR and ΔatsRΔtecA culture supernatants, indicating that deletion of tecA 152 
does not affect the T6SS apparatus (Figure S1C). When overexpressed in ΔatsR and the 153 
isogenic T6SS-deficient ΔatsRΔhcp mutant, low amounts of TecA were predominantly 154 
and reproducibly detected in culture supernatants of ΔatsR but not ΔatsRΔhcp despite a 155 
similar TecA expression found in cell lysates of the two bacterial strains (Figure S1C). 156 
Chromosomally encoded TecA was not detectable initially in ΔatsR cell lysates by the 157 
routine immunoblotting assay (Figure S1C), but became detectable upon increasing 158 
sample loading and exposure time of the immunoblot (Figure S1D), suggesting a low 159 
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expression of TecA in in vitro cultured bacteria. Together, these data suggest the need of 160 
a functional T6SS for TecA secretion, as expected for a bona fide T6SS effector protein. 161 
Like B. cenocepacia K56-2, B. multivorans ATCC17616 also infects, survives and 162 
replicates within macrophages (Schmerk and Valvano, 2013). B. multivorans 163 
ATCC17616 possesses two T6SS clusters and an atsR ortholog (Bmul_5222, herein 164 
named atsRBm), but lacks a tecA homolog. Culture supernatant of B. multivorans 165 
ATCC17616 ΔatsRBm showed a similar expression of Hcp as that of B. cenocepacia K56-166 
2 ΔatsR, suggesting that the T6SSs in B. multivorans ATCC17616 are functional (Figure 167 
S1E). However, ΔatsRBm could not induce the “beads on a string”-like phenotype in 168 
infected macrophages (Figure 1D). Notably, heterologous expression of TecA in ΔatsRBm 169 
enabled this bacterium to induce cytoskeletal rearrangements comparable to those found 170 
in B. cenocepacia (Figure 1C-D). These data strongly indicate that T6SS-translocated 171 
TecA is both necessary and sufficient to drive cytoskeletal defects in infected 172 
macrophages. 173 
 174 
B. cenocepacia infection induces Asn-41 deamidation of RhoA due to a putative 175 
T6SS effector activity 176 
B. cenocepacia K56-2 and J2135 are clonally related and often used indistinctly 177 
(Mahenthiralingam et al., 2000). Unlike K56-2, J2315 lacks the ability to produce O 178 
antigen lipopolysaccharide (Ortega et al., 2005) and consequently infects macrophages 179 
more readily (Saldías et al., 2009). J2315 can induce similar “beads on a string”-like 180 
structures in macrophages, which does not require deletion of atsR. We recently 181 
discovered that intracellular J2315 infection resulted in the T6SS-dependent inactivation 182 
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of RhoA by inducing deamidation of asparagine-41 (Asn-41) (Xu et al., 2014), a residue 183 
located in the switch-I region of the GTPase. This observation was confirmed here by 184 
mass spectrometry analyses of FLAG-RhoA purified from murine dendritic DC2.4 cells 185 
infected with J2315 or its T6SS-defective Δhcp mutant (Figure 2A). The C. botulinum 186 
ADP-ribosylation C3 toxin modifies Asn-41, generating a mobility shift of RhoA on 187 
SDS-polyacrylamide gels. This mobility shift provided a convenient assay, which 188 
confirmed the deamidation modification of RhoA induced J2315 infection (Figure 2A). 189 
Notably, we observed that RhoA from non-infected cells, upon incubation with cytosolic 190 
extracts of J2315 but not its ΔHcp mutant-infected cells, also resisted C3 toxin 191 
modification (Figure 2B). The Rho-modifying activity could also be recapitulated from 192 
the pellets of J2315-infected macrophages (containing the bacteria and proteins expressed 193 
within the bacteria), but unlike the situation in the bacteria-free cytosol, the activity was 194 
not dependent on the T6SS (Figure 2C). Together, these data strongly indicate that B. 195 
cenocepacia expresses a T6SS effector that deamidates RhoA upon translocation from 196 
the bacteria into the host cytosol, also excluding the possibility that infection-induced 197 
RhoA deamidation is host-derived. Supporting this idea, we found that lysates of in vitro 198 
cultured B. cenocepacia, but not those of E. coli and B. thailandensis, showed a similar 199 
activity that renders RhoA resistant to further modification by the C3 toxin (Figure 2D). 200 
Consistently, RhoA recombinantly expressed and purified from B. cenocepacia showed a 201 
deamidation modification on Asn-41, contrasting to recombinant RhoA purified from the 202 
conventional E. coli host (Figure 2E). 203 
 204 
The T6SS effector TecA mediates RhoA deamidation in vivo and in vitro 205 
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Also in the experiments described above, we found that RhoA purified from the ΔtecA 206 
strain of B. cenocepacia was not deamidated and showed the same mass as that from E. 207 
coli (Figure 2E), suggesting that TecA is the candidate T6SS effector that causes RhoA 208 
deamidation. We further observed that deamidation of RhoA did not occur in DC2.4 cells 209 
infected with the ΔtecA isogenic mutant of J2315, similarly as in infections with the Δhcp 210 
mutant (Figure 3A). Complementing TecA expression in ΔtecA by a tecA-encoding 211 
plasmid restored the protection of RhoA from C3 toxin-catalyzed ADP-ribosylation 212 
(Figure 3B). Further, introducing the TecA-expression plasmid in B. thailandensis, which 213 
harbors a similar T6SS, resulted in the same modification of RhoA upon infection of 214 
DC2.4 cells, which did not occur in cells infected with bacteria expressing the 215 
enzymatically inactive TecAC41A (see below) (Figure 3C). These results demonstrate that 216 
TecA is essential for the T6SS-mediated Asn-41 deamidation of RhoA. Exogenous 217 
expression of TecA, but not TecAC41A, in 293T cells recapitulated the same results as 218 
those observed in infected DC2.4 cells (Figure 3D). Mass spectrometry of FLAG-RhoA 219 
purified from 293T cells confirmed the conversion of Asn-41 into an aspartic acid 220 
(Figure 3E). Same results were observed in E. coli co-expressing RhoA and the TecA or 221 
TecAC41A proteins (Figure 3F). These data demonstrate that TecA is required and 222 
sufficient for deamidation of the Asn-41 residue in RhoA. 223 
Previous work showed that the B. cenocepacia T6SS is needed to deactivate the Rho-224 
family Rac1 and Cdc42 GTPases (Flannagan et al., 2012; Rosales-Reyes et al., 2012). 225 
We therefore investigated Rac1 expressed in 293T cells together with TecA. Mass 226 
spectrometry confirmed that the peptide containing Asn-39 in Rac1 (equivalent to Asn-41 227 
in RhoA) was modified to aspartic acid by TecA (Figure 3G), indicating TecA causes the 228 
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same modification in other Rho-family members by targeting the conserved asparagine in 229 
the switch I region. Notably, when we transiently expressed the deamidated Rac1 (N39D) 230 
or RhoA (N41D) alone in 293T cells, the “beads on a string”-like structure was readily 231 
observed in cells expressing Rac1 N39D but not RhoA N41D (Figure 3H). These suggest 232 
that TecA-induced Rac1 deamidation and inactivation is responsible for the actin 233 
cytoskeleton disruption caused by B. cenocepacia infection. 234 
 235 
The TecA effector defines a family of bacterial deamidases that modify Rho 236 
GTPases 237 
TecA is a 159-amino acid protein of predicted unknown function. As expected for a 238 
T6SS substrate, TecA lacks a canonical N-terminal signal peptide. No putative conserved 239 
domains could be detected using PFAM and HHPred, and we also failed to identify any 240 
evident primary sequence similarity between TecA and known deamidases or other 241 
enzymes with hydrolytic activity. BLAST searches uncovered TecA orthologs in B. 242 
cenocepacia BC7, H111, AU1054, HI2424, H111, and MC0-3, (sharing over 91-99% 243 
amino acid identity with TecA of K56-2 and J2315), and in B. contaminans, B. 244 
pyrrocinia, B. lata, B. cepacia ATCC25416, B. cenocepacia PC184, and B. ubonensis 245 
(sharing 75-85% amino acid identity with TecA) (Figure 4A), suggesting that TecA is 246 
prevalent in a subset of Burkholderia species. Several additional homologs, sharing from 247 
37 to 50% amino acid identity with TecA were also found in Alcaligenes faecalis, 248 
Chryseobacterium indologenes, the fish pathogen Flavobacterium branchiophilum FL-249 
15, and the opportunistic pathogen and symbiont Ochrobactrum anthropi ATCC49188 250 
(Figure 4A). Sequence alignments of these proteins revealed a conserved Cys-His-Asp 251 
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triad (Cys-41, His-105, and Asp-148 in TecA). The Cys-His-Asp/Asn/Glu/Gln triad 252 
forms a catalytic pocket in many proteases and protease-like hydrolytic enzymes 253 
including deamidases (Cui et al., 2010; Washington et al., 2013; Yao et al., 2012). The 254 
cysteine, activated by the histidine and sometimes the nonessential third residue in the 255 
triad, serves as the catalytic nucleophile. Interestingly, in silico structural modeling of 256 
TecA using I-TASSER (Roy et al., 2010) revealed a similar structural fold with various 257 
cysteine protease families including proteins containing the NlpC/P60, cysteine-histidine 258 
hydrolase, and papain-like cysteine peptidase domains (PDB accessions 2EVR, 2FG0, 259 
2HBW, 4F88, 3GQJ, and 3S0Q). The predicted TecA model revealed the putative 260 
catalytic Cys-41 and His-105 residues situated in positions consistent with a catalytic 261 
triad typical of cysteine proteases and protease-like hydrolases, further supporting the 262 
hypothesis that TecA is a cysteine protease-like hydrolase (Figure 4B). Thus, despite the 263 
lack of significant primary sequence similarity, TecA likely adopts a three-dimensional 264 
fold characteristic of members of the cysteine protease family.  265 
Mutagenesis was then carried out to test the deamidase activity of TecA and its 266 
orthologs. Alanine substitution of Cys-41 and His-105 in TecA abrogated Asn-41 267 
deamidation of RhoA and Rac1 in the 293T cells co-expression system (Figure 5A and 268 
Figure 3D, 3E and G). The TecAD148A was partially active, but removal of the C-terminal 269 
20 residues containing the Asp-148 resulted in a completely inactive enzyme (Figure 5A). 270 
TecAC41A was also unable to deamidate Asn-41 in RhoA in the E. coli expression assay 271 
(Figure 3F). Upon DC2.4 infection with B. cenocepacia or B. thailandensis strains 272 
expressing the T6SS, TecAC41A failed to induce RhoA deamidation (Figure 3C and data 273 
not shown). Co-expression of RhoA and TecA orthologues from C. indologenes 274 
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(WP_034735953), F. branchiophilum (WP_014085254), and O. anthropi 275 
(WP_011982319) in 293T cells gave the same results as with B. cenocepacia TecA, 276 
namely protection of RhoA from C3 toxin-mediated ADP-ribosylation (Figure 5B). 277 
Further, replacement of the putative catalytic Cys-40, His-104, or Asp-149 in 278 
WP_034735953 with alanine abrogated the protective effect on RhoA from C3 toxin-279 
catalyzed modification (Figure 5C). Mass spectrometry confirmed that WP_034735953 280 
deamidated RhoA and Rac1 in 293T cells at Asn-41 and Asn-39, respectively, and this 281 
modification did not occur with the C40A mutant protein (Figure 5D). Together, these 282 
results demonstrate that B. cenocepacia TecA epitomizes a family of bacterial proteins 283 
specifically catalyzing asparagine deamidation of Rho GTPases in mammalian cells. 284 
 285 
TecA deamidation of RhoA mediates B. cenocepacia-induced Pyrin inflammasome 286 
activation 287 
Our recent studies suggest that the Pyrin inflammasome senses Rho inactivation induced 288 
by bacterial Rho-modifying agents (Xu et al., 2014). Therefore, we examined whether 289 
TecA deamidation of host Rho GTPases could activate the Pyrin inflammasome. 290 
Confirming our previous observation (Xu et al., 2014), infection of primary mouse bone 291 
marrow macrophages (BMDMs) with B. cenocepacia J2315, but not the Δhcp mutant, 292 
stimulated caspase-1 autoprocessing, pyroptotic cell death and IL-1β secretion (Figure 293 
6A and 6B), hallmarks of canonical inflammasome activation. These proinflammatory 294 
responses were absent in BMDMs derived from Mefv-/- mice (Mefv is the gene encoding 295 
Pyrin). Importantly, the ΔtecA mutant strain behaved similarly as Δhcp, failing to induce 296 
caspase-1 activation, pyroptosis and IL-1β secretion (Figure 6A and 6B). Restoring TecA 297 
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expression in ΔtecA restored B. cenocepacia-induced caspase-1 activation and pyroptosis 298 
in primary BMDMs (Figure 6C and 6D). In contrast, TecA mutants in the three putative 299 
catalytic residues (C41A, H105A and D148A) did not restore the infection-triggered 300 
inflammasome responses (Figure 6C and 6D). Similar results were obtained with B. 301 
cenocepacia infections in DC2.4 cells (Figure 6E). Furthermore, we generated the N41L 302 
mutant of RhoA as well as the equivalent N39L mutants of Rac1 and Cdc42. When the 303 
deamidation-resistant mutant Rho was overexpressed in DC2.4 cells, we found that RhoA 304 
N41L could evidently inhibit B. cenocepacia infection-induced Pyrin inflammasome 305 
activation (Figure 6F). In contrast, neither the N39L mutants of Rac1/Cdc42 nor wild-306 
type RhoA showed such dominant-negative effects (Figure 6F). These data are consistent 307 
with our previous observation that modification of RhoA but not other GTPase substrates 308 
induces Pyrin inflammasome activation (Xu et al., 2014), and strongly suggest that TecA-309 
mediated deamidation of RhoA is responsible for B. cenocepacia-stimulated Pyrin 310 
inflammasome activation. 311 
 312 
TecA mediates B. cenocepacia-induced lung inflammation and its recognition by 313 
Pyrin can protect mice from lethal infection 314 
Intranasal B. cenocepacia infection of wild-type mice triggered strong lung inflammation, 315 
evidenced by massive infiltration of inflammatory cells, appearance of intra-alveolar 316 
leukocytes, and destruction of the normal lung architecture due to activation of the Pyrin 317 
inflammasome (Xu et al., 2014) (Figure 7A). In contrast, mice infected with B. 318 
cenocepacia ΔtecA showed negligible lung inflammation. Expressing wild type but not 319 
the deamidase-defective TecAC41A protein in the mutant bacteria restored the strong 320 
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inflammation in the infected lungs (Figure 7A). These observations were also evident 321 
from the clinical pathology scores that measure the lung damage (Figure 7B). Thus, the 322 
TecA deamidase activity induces Pyrin inflammasome-mediated inflammation due to its 323 
modification and inactivation of host Rho GTPases. To further demonstrate the functional 324 
significance of this innate immune recognition, peritoneal infection of mice with B. 325 
cenocepacia was performed. At the infection dose of 2 × 108 bacteria, nearly all the mice 326 
could resist wild-type B. cenocepacia infection, but the large majority of infected mice 327 
succumbed to the ΔtecA mutant bacteria (Figure 7C). The lethality is presumably caused 328 
by loss of the inflammation and consequently attenuated control of bacterial replication in 329 
the mice. Consistently, a higher number of B. cenocepacia ΔtecA than that of wild-type 330 
bacteria was recovered from the spleen of infected mice (Figure 7D). The bacterial loads 331 
in the liver showed a similar trend despite that the difference was not statistically 332 
significant. When the infection was performed with the Mefv-/- mice, wild-type B. 333 
cenocepacia infection also became lethal and showed a comparable lethality as the ΔtecA 334 
mutant bacteria (Figure 7C). These results highlight the protective role of Pyrin 335 
inflammasome that functions through detecting the Rho deamidase activity of TecA in B. 336 
cenocepacia. 337 
 338 
DISCUSSION 339 
We show that TecA is a single, non-VgrG T6SS effector protein that elicits actin 340 
cytoskeletal defects, inflammation, and macrophage pyroptosis by inactivating Rho 341 
GTPases through deamidation of an asparagine residue within the GTPase switch I 342 
region. Rho GTPases are central molecular switches of eukaryotic cells that cycle 343 
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between the inactive GDP-bound and active GTP-bound states and regulate key signaling 344 
pathways concerning cytoskeletal dynamics, trafficking, immune responses, and cell 345 
proliferation (Aktories, 2011). Not unexpectedly, many microbes produce proteins that 346 
target Rho GTPase signaling either by direct covalent modification of the GTPases or by 347 
manipulating their upstream and downstream regulators and effectors (Aktories, 2011). 348 
Pathogen effectors can block Rho GTPases activation, causing inhibition of cell 349 
migration and phagocytosis and disruption of the actin cytoskeleton, while in other cases 350 
can activate the GTPases to mediate bacterial entry into the cytosol. Alteration of the 351 
actin cytoskeletal dynamics is a typical cellular response to both inactivated and activated 352 
Rho GTPases, and recent evidence suggests that pathogen-induced "unnatural" actin 353 
dynamics is sensed by host innate immunity. For example, activation of Rac1/Cdc42 by 354 
the Salmonella enterica Type III effector SopE stimulates host NOD1 signaling leading 355 
to the induction of NF-κB-dependent inflammatory responses (Keestra et al., 2013), 356 
while RhoA inactivation causes Pyrin inflammasome activation (Xu et al., 2014).  357 
TecA defines a new family of bacterial deamidases that are deployed by the T6SS 358 
upon bacterial intracellular infection. Enzymatic deamidation is a common pathogenic 359 
strategy utilized by a broad range of bacterial pathogens that infect plants and animals 360 
(Washington et al., 2013). Deamidation causes the replacement of an amide group with a 361 
carboxylate group, converting glutamine and asparagine into glutamic acid and aspartic 362 
acid, respectively. Several families of bacterial deamidases are known, which target 363 
various eukaryotic proteins that play key roles in cellular physiology. E. coli (CNF1, 364 
CFN2, CNF3) and Yersinia pseudotuberculosis (CNFY) cytotoxic necrotizing factors 365 
(Flatau et al., 1997; Lockman et al., 2002; Schmidt et al., 1997) and the Vibrio 366 
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parahaemolyticus type III effector VopC (Zhang et al., 2012) target a glutamine residue 367 
in the switch II domain of Rho GTPases, which leads to constitutive activation resulting 368 
in cytoskeletal rearrangements. BLF1 is a lethal toxin from B. pseudomallei that inhibits 369 
host protein synthesis via deamidation of the translation factor eIF4A (Cruz-Migoni et al., 370 
2011). Pasteurella multocida toxin PMT activates heterotrimeric G proteins affecting 371 
several downstream signaling pathways (Orth et al., 2009). Further, cell cycle-inhibiting 372 
factors from multiple bacterial species inhibit ubiquitination pathways by deamidating 373 
Glu-40 of ubiquitin and the ubiquitin-like protein NEDD8 (Cui et al., 2010), while 374 
Shigella flexneri has evolved a type III effector protein that dampens TRAF6-mediated 375 
immune responses by deamidating UBC13 (Sanada et al., 2012). It is worth noting that 376 
TecA is the first known bacterial deamidase with specificity for asparagine and an 377 
inhibitory effect on Rho GTPases.  378 
TecA and its orthologs do not share primary amino acid sequence homology with 379 
other known bacterial deamidases, and represent a novel class of deamidases. The TecA 380 
family has a putative catalytic triad consisting of invariant cysteine, histidine and aspartic 381 
acid residues, characteristic of the papain-like superfamily of hydrolytic enzymes 382 
(Washington et al., 2013). Like other bacterial deamidases acting on Rho GTPases such 383 
as CNF1 and CNFY, both RhoA and Rac1 can be TecA substrates. Previous data indicate 384 
that Cdc42 is inactivated by the B. cenocepacia T6SS in murine macrophages (Flannagan 385 
et al., 2012; Rosales-Reyes et al., 2012), suggesting that this GTPase might also be a 386 
TecA substrate. As with CNFI (Flatau et al., 2000), TecA likely recognizes a relatively 387 
short, common structural element in the switch-I region that would explain its ability to 388 
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work with multiple substrates, but additional experimentation is required to investigate 389 
this hypothesis. 390 
Deamidation is enzymatically irreversible, making deamidases potent virulence 391 
factors (Washington et al., 2013). This is underscored by the robust effect of TecA on the 392 
innate immune responses and inflammation, as we have observed in infected 393 
macrophages and mice. The pro-inflammatory potential of B. cenocepacia has long been 394 
recognized, especially in the context of cystic fibrosis (Abdulrahman et al., 2011; 395 
Downey et al., 2007; Kopp et al., 2012). Our results convincingly demonstrate that lung 396 
inflammation upon B. cenocepacia infection depends on an enzymatically active TecA 397 
and highlight the importance of the Pyrin inflammasome in innate immune detection of 398 
B. cenocepacia (Xu et al., 2014). Indeed, Pyrin responds to pathogen modification and 399 
inactivation of Rho GTPases, which echoes the “guard hypothesis” in plant immunity 400 
(Xu et al., 2014; Yang et al., 2014). The effect of TecA-mediated Rho deamidation on the 401 
actin cytoskeleton of B. cenocepacia-infected cells and the fact that Pyrin and the Pyrin-402 
ASC complexes localize to actin filaments (Mansfield et al., 2001; Waite et al., 2009), 403 
strongly suggest that Pyrin could be a sensor for actin homeostasis. In this context, the 404 
identification of TecA also provides a tool for future dissection of the pathway leading to 405 
Pyrin inflammasome activation.  406 
 407 
EXPERIMENTAL PROCEDURES 408 
Bacterial strains and plasmids 409 
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Strains and plasmids used in this study are listed in Table S1. Details on bacterial growth 410 
conditions, DNA transformation and triparental mating, and the cloning of TecA, RhoA 411 
and Rac1 coding sequences are also in the Supplementary Experimental Procedures.  412 
 413 
Deletion and transposon mutagenesis 414 
Unmarked and non-polar deletions in B. cenocepacia K56-2 and J2315 strains, and in B. 415 
multivorans ATCC17616 were performed as described previously (Flannagan et al., 416 
2008; Hamad et al., 2010). Random transposon mutagenesis in B. cenocepacia K56-2 417 
ΔatsR was performed using the pTnMod-RTp’ plasposon (Dennis and Zylstra, 1998). For 418 
further details, see the Supplementary Experimental Procedures.  419 
 420 
Cell culture and transfection 421 
293T cells and mouse BMDMs were cultured in DMEM (HyClone), while mouse DC2.4 422 
dendritic cells were cultured in RPMI-1640.  Details on culturing conditions and 423 
transfection are in the Supplementary Experimental Procedures.  424 
 425 
Macrophage infections 426 
To quantify the T6SS-dependent "beads on a string" phenotype (Aubert et al., 2015), 427 
infections were performed in the C57BL/6 murine bone marrow-derived macrophage cell 428 
line ANA-1 (Cox et al., 1989). Infection of DC2.4 dendritic cells and iBMDM cells was 429 
used to determine RhoA modification and inflammasome activation. Additional details 430 
are presented in Supplementary Experimental Procedures. 431 
 432 
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Hcp and TecA polyclonal antibodies and immunoblot analysis of TecA secretion 433 
Hcp was PCR amplified and cloned into pET30a by use of NdeI and HindIII restriction 434 
sites, and introduced into E. coli strain BL21 (DE3) by transformation, generating 435 
pDA44. Hcp fused to 6xHis was purified and used to raise rabbit polyclonal antibodies. 436 
The peptide TRFNFETGDQWDGR from TecA was synthesized by ProSci Inc. (Poway, 437 
CA) and employed for rabbit immunization. See further details in Supplementary 438 
Experimental Procedures. 439 
 440 
Inflammasome activation assays 441 
Culture supernatants of primary BMDMs or EGFP-Pyrin-expressing DC2.4 cells that had 442 
been treated with indicated inflammasome stimuli were subjected to 15% trichloroacetic 443 
acid precipitation. Precipitates were analysed by anti-caspase-1 immunoblotting, and the 444 
total cell lysates were analyzed by anti-β-tubulin blotting as the loading control. IL-1β 445 
secretion was measured using the IL-1β ELISA kit (Neobioscience Technology 446 
Company). To determine pyroptotic cell death, the lactate dehydrogenase (LDH) assay 447 
was employed using the CytoTox 96 Non-Radioactive Cytotoxicity Assay kit (Promega).  448 
 449 
Purification of recombinant proteins and in vitro deamidation reaction 450 
His-tagged proteins were purified by affinity chromatography using Ni-NTA beads 451 
(Qiagen). For in vitro deamidation reaction, parental or mutant TecA recombinant 452 
proteins were incubated for 30 min at 37°C with RhoA (1:10 molar ratio) in a buffer 453 
made of 50 mM Tris-HCl (pH 7.5) and 150 mM NaCl. The resulting modified Rho 454 
proteins were subjected to mass spectrometry analyses directly or reaction with the C3 455 
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toxin. Approximately 0.1 µg of C3 toxin-reacted RhoA was separated on 15% SDS-456 
PAGE gels followed by anti-RhoA immunoblotting. See further details in Supplementary 457 
Experimental Procedures. 458 
 459 
Gel shift assay of RhoA ADP-ribosylation by the C3 toxin 460 
DC2.4 or 293T cells were lysed by sonication in a buffer containing 20 mM Tris-HCl 461 
(pH 7.5), 150 mM NaCl, 20 mM β-OG and a protease inhibitor cocktail. The lysates were 462 
cleared by centrifugation at 16,000 g for 10 min. 15 µl of the supernatants were incubated 463 
with1 µg of recombinant C3 toxin with NAD and thymidine for 15 min at 30 °C and the 464 
reaction was stopped by adding SDS sample buffer. Cells lysates were separated by SDS-465 
PAGE in 15% SDS-polyacrylamide gels and analyzed by immunoblotting. 466 
 467 
Mice infections 468 
Cultures of B. cenocepacia J2315, ΔtecA or ΔtecA complemented with pTecA were used 469 
to infect C57BL/6 wild-type or Mefv-/- mice intranasally to examine lung inflammation or 470 
intraperitoneally to investigate the lethal effect and bacteria loads. Lungs were removed 471 
for histopathology and sections stained with haematoxylin and eosin, and the damage of 472 
infected lungs was quantified by blindly scoring of the pathology. See further details in 473 
Supplementary Experimental Procedures. Animal experiments were conducted following 474 
the Ministry of Health national guidelines for housing and care of laboratory animals and 475 
performed in accordance with institutional regulations after review and approval by the 476 
Institutional Animal Care and Use Committee at National Institute of Biological 477 
Sciences. 478 
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SUPPLEMENTAL INFORMATION  480 
Supplemental Information includes Supplementary Experimental Procedures, 481 
Supplementary Figure 1 and Supplementary Table 1.  482 
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FIGURE LEGENDS 702 
Figure 1.  Identification of tecA Encoding A Novel Non-VgrG T6SS Effector 703 
Functioning in Eukaryotic Host Cells. 704 
(A) Genetic map of the B. cenocepacia K56-2 T6SS gene cluster located on chromosome 705 
1 (Chr. 1) and the tecA (BCAM1857) region on chromosome 2 (Chr. 2). Arrows indicate 706 
direction of transcription of each gene. Genes outside the T6SS cluster are indicated in 707 
black. hcp and tecA are highlighted in red. White circles indicate the position of the 708 
transposon insertion. 709 
(B) Phase-contrast microscopy of ANA-1 macrophages at 4 h post-infection (MOI of 50) 710 
with B. cenocepacia K56-2 ΔatsR and ΔatsRΔtecA carrying the vector control pDA12 or 711 
complementing plasmid pTecA. The arrows indicate “beads on a string”-like structures. 712 
(C) Quantification of the development of “beads on a string”-like structures in B. 713 
cenocepacia-infected ANA-1 macrophages. Results were expressed in arbitrary units 714 
relative to ΔatsR set as 1. Values are mean ± standard deviation from at least 21 fields of 715 
view, and representative of three independent experiments. Cells infected with B. 716 
cenocepacia K56-2 ΔatsRΔhcp were used as negative control. 717 
(D) Phase-contrast microscopy of ANA-1 macrophages infected with B. multivorans 718 
ΔatsRBm using the same conditions as in (B). The arrows mark the “beads on a string”-719 
like structures. 720 
See also Figure S1. 721 
 722 
Figure 2. A T6SS-dependent Activity in B. cenocepacia That Leads to Rho 723 
Deamidation. 724 
 32 
(A) T6SS-dependent Asn-41 deamidation of RhoA during B. cenocepacia infection. 725 
FLAG-RhoA was stably expressed and purified from DC2.4 cells infected with B. 726 
cenocepacia J2315 or its Δhcp mutant, and analysed by mass spectrometry. The upper 727 
panel shows the extracted ion chromatograms of the Asn-41-containing peptide. The 728 
lower panel shows the behavior of endogenous RhoA in response to further modification 729 
by the C3 toxin. 730 
(B) RhoA modification by cytosolic extracts of B. cenocepacia-infected cells. RhoA 731 
purified from non-infected DC2.4 cells was incubated with cytosolic extracts of DC2.4 732 
cells infected with J2315 or Δhcp, and then subjected to further in vitro modification by 733 
the C3 toxin. Anti-tubulin immunoblot serves as the loading control. 734 
(C) Reconstitution of RhoA modification by bacteria-containing pellets of J2315-infected 735 
cell lysates. Pellets of lysates of DC2.4 cells infected with J2315 or Δhcp were used as 736 
the source of activity to modify RhoA from non-infected DC2.4 cells. RhoA was 737 
subjected to further in vitro modification by the C3 toxin. Anti-tubulin immunoblot 738 
serves as the loading control. 739 
(D) RhoA modification by lysates of J2315 but not E. coli and B. thailandensis (B.t.). 740 
RhoA from non-infected DC2.4 cells was incubated with the indicated bacterial lysates 741 
and subjected to further in vitro modification by the C3 toxin. Anti-tubulin immunoblot 742 
serves as the loading control. 743 
(E) Asn-41 deamidation of RhoA in J2315 but not E. coli. WT or the N41A mutant RhoA 744 
was recombinantly expressed and purified from B. cenocepacia (WT or ΔtecA) or E. coli. 745 
The purified RhoA was subjected to further in vitro modification by the C3 toxin (upper) 746 
or mass spectrometry analyses. The lower panel shows the extracted ion chromatograms 747 
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of the Asn-41-containing peptide of RhoA from B. cenocepacia (B.c.) and E. coli. 748 
Spectrum 1/2 and 3/4 are from two separate experiments. 749 
 750 
Figure 3. TecA Induces Rho Deamidation in Various Cellular Systems and Causes 751 
Actin Cytoskeleton Disruption.  752 
(A and B) Modification of endogenous RhoA by TecA during B. cenocepacia infection. 753 
DC2.4 cells were infected with J2315 or the indicated mutant strains. Cell lysates were 754 
subjected to in vitro modification by the C3 toxin followed by immunoblotting analyses. 755 
An empty vector (Vec) or a plasmid expressing TecA was introduced into ΔtecA in (B). 756 
 (C) Ectopic expression of TecA in B. thailandensis induces endogenous RhoA 757 
modification during infection. DC2.4 cells were infected with B. thailandensis harboring 758 
an empty vector (Vec) or a TecA-expressing plasmid, or B. cenocepacia J2315 as a 759 
control. Assay of RhoA modification was performed similarly as that in (A). C41A is a 760 
catalytic cysteine mutant of TecA. 761 
(D and E) Asn-41 deamidation of RhoA by TecA in transfected 293T cells. 293T cells 762 
were transfected with Myc-tagged TecA (WT or the C41A mutant). Endogenous RhoA 763 
modification in (D) was detected as in (A). In (E), cells were co-transfected with FLAG-764 
RhoA and purified FLAG-RhoA was subjected to mass spectrometry analyses; shown are 765 
extracted ion chromatograms of the Asn-41-containing peptide. 766 
(F) Asn-41 deamidation of RhoA by TecA co-expressed in E. coli. E. coli BL21 strain 767 
was transformed with two plasmids expressing His-RhoA and TecA (WT or the C41A 768 
mutant). Purified His-RhoA was subjected to mass spectrometry analyses and shown are 769 
extracted ion chromatograms of the Asn-41-containing peptide. 770 
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 (G) Asn-39 deamidation of Rac1 by TecA in 293T cells. 293T cells were co-transfected 771 
with FLAG-Rac1 and Myc-TecA (WT or the C41A mutant). FLAG-Rac1 deamidation 772 
was assayed by mass spectrometry and extracted ion chromatograms of the Asn-39-773 
containing peptide are shown. 774 
(H) Deamidated Rac1 mimics TecA to alter the actin cytoskeleton structure. 293T cells 775 
were transfected with RhoA N41D or Rac1 N39D mutant together with EGFP as the 776 
transfection marker. Shown are the confocal fluorescence images of representative 777 
transfected cells. The arrows indicate “beads on a string”-like structures. 778 
 779 
Figure 4. The TecA Family of Bacterial Proteins with Putative Cysteine Protease-780 
like Fold and Catalytic Triad. 781 
(A) ClustalW analysis of TecA orthologs ordered based on their sequence identity to 782 
TecA of B. cenocepacia K56-2 (which is 100% identical to TecA of J2315). TecA 783 
orthologs are present in B. cenocepacia (B. ceno), B. contaminans (B. cont), B. pyrrocinia 784 
(B. pyrr), B. lata, B. cepacia ATCC25416 (B. cep), B. ubonensis (B. ubo), Alcaligenes 785 
faecalis, Chryseobacterium indologenes, Flavobacterium branchiophilum, and 786 
Ochrobactrum anthropi. Conserved residues are depicted in red. Asterisks indicate the 787 
putative Cys-His-Asp catalytic triad residues.  788 
(B) In silico predicted structural model of B. cenocepacia K56-2 TecA, showing the 789 
location of the critical Cys-41 and His-105 residues of the putative catalytic triad. The 790 
Asp-148 is in a predicted unstructured region and therefore not indicated in the model. 791 
 792 
Figure 5. TecA and Its Homologs Can Deamidate Rho GTPases In Vitro. 793 
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(A) Putative Cys-His-Asp catalytic triad residues are important for TecA modification of 794 
RhoA. 293T cells were transfected with Myc-TecA (WT or indicated mutants). Cell 795 
lysates were subjected to in vitro modification by the C3 toxin followed by 796 
immunoblotting. ΔC20 lacks the C-terminal 20 residues of TecA.  797 
(B) RhoA modification by TecA homologs in 293T cells. 293T cells were transfected 798 
with mammalian expression plasmids encoding WP_034735953 (C. indologenes), 799 
WP_014085254 (F. branchiophilum) or WP_011982319 (O. anthropi). Cell lysates were 800 
subjected to in vitro modification by the C3 toxin followed by immunoblotting. 801 
(C and D) Recombinant WP_034735953 from C. indologenes deamidates RhoA and 802 
Rac1 in vitro. Recombinant His-tagged WP_034735953 (WT or the catalytic cysteine 803 
mutant C40A) was incubated with purified RhoA or Rac1. Assay of RhoA modification 804 
by the C3 toxin in (C) was similar to that in (A). RhoA and Rac1 after incubation were 805 
analyzed by mass spectrometry. Shown in (D) are the extracted ion chromatograms of the 806 
peptide containing Asn-41 (for RhoA) or Asn-39 (for Rac1).  807 
 808 
Figure 6. TecA Deamidation of RhoA Mediates B. cenocepacia-induced Pyrin 809 
Inflammasome Activation. 810 
(A-D) TecA mediates B. cenocepacia infection-induced Pyrin inflammasome activation 811 
in its deamidase activity-dependent manner in mouse macrophages. Primary bone 812 
marrow-derived macrophage (BMDM) cells derived from WT (C57BL/6) or Mefv-/- mice 813 
were infected with wild-type B. cenocepacia J2315 or its ΔtecA mutant or stimulated with 814 
LPS plus nigericin (Nig) as a control. Cell supernatants were examined by 815 
immunoblotting with anti-caspase-1 in (A and C) (immunoblotting of tubulin in the cell 816 
 36 
lysates serves as a loading control). Pro-Casp1, caspase-1 precursor; p10, the mature 817 
caspase-1. ELISA of IL-1β release and pyroptotic cell death measured by LDH release 818 
(n=3; mean ± SD) are shown in (B and D). In (C and D), ΔtecA was complemented with a 819 
plasmid expressing WT TecA or the indicated catalytic mutants. 820 
(E) TecA mediates B. cenocepacia infection-induced Pyrin inflammasome activation in 821 
DC2.4 cells. DC2.4 cells stably expressing Pyrin were infected with B. cenocepacia 822 
J2315 or the indicated mutant and complementation strains similarly as in (A and C). Cell 823 
supernatants were examined by anti-caspase-1 immunoblotting; immunoblotting of 824 
tubulin in the cell lysates serves as a loading control. Pro-Casp1, caspase-1 precursor; 825 
p10, the mature caspase-1. 826 
 (F) A deamidation-resistant mutant RhoA inhibits B. cenocepacia-induced Pyrin 827 
inflammasome activation. DC 2.4 cells stably expressing FLAG-tagged wild-type RhoA 828 
or the denoted N/L mutant of RhoA, Rac1 or Cdc42 were infected with B. cenocepacia 829 
J2315. The supernatant were subjected to anti-caspase-1 immunoblotting.  830 
Immunoblotting of tubulin in cell lysates serves as a loading control. Anti-FLAG 831 
immunoblot in the lower panel shows the expression of exogenous Rho GTPases. Pro-832 
Casp1, caspase-1 precursor; p20, the mature caspase-1. 833 
 834 
Figure 7. The Rho Deamidase Activity of TecA Triggers Inflammation and Its 835 
Recognition by Pyrin Protects Mice from Lethal B. cenocepacia Infection.  836 
(A and B) WT C57BL/6 mice were infected with B. cenocepacia J2315 wild-type strain, 837 
or ΔtecA, or ΔtecA containing a plasmid expressing TecA (WT or the C41A mutant). 838 
Representative haematoxylin & eosin staining of the lung sections is shown in (A). 839 
 37 
Quantification scores of the lung injury ((n=2; mean ± SD) are shown in (B). Data shown 840 
are representative of two independent repetitions. 841 
(C) Survival of mice (WT and Mefv-/-) following peritoneal infection of B. cenocepacia 842 
J2315 (wild-type or the ΔtecA strain). Survival curve analysis was performed with the 843 
log-rank (Mantel–Cox) test in GraphPad Prism 5 (*P ≤  0.05). Data shown are 844 
representative of three independent experiments. 845 
(D) Bacterial loads in the spleen and liver of mice intraperitoneally infected with B. 846 
cenocepacia J2315 (wild-type or the ΔtecA strain). Colony-forming units (CFUs) per 847 
gram of tissues 4 days after infection are shown as mean values (n=7). *P ≤ 0.05; ns, 848 
non-significant (two-tailed unpaired Student’s t-test).  849 
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